Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANE SHEETS

v3.19.1
CONDENSED CONSOLIDATED BALANE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 207,250 $ 96,473
Accounts receivable, net 144,383 143,907
Inventory, net 44,610 42,299
Other current assets and prepaid expenses 38,994 35,052
Total current assets 435,237 317,731
Property, plant and equipment, net 139,965 144,674
Intangible assets, net 597,316 614,452
In-process research and development 635,561 635,572
Goodwill 698,522 700,193
Investments 32,297 31,228
Operating lease right-of-use assets 33,277  
Other assets 3,126 7,222
Total assets 2,575,301 2,451,072
Current liabilities:    
Accounts payable 51,085 47,395
Accrued expenses 217,534 203,513
Current maturities of operating leases 15,123  
Current portion of convertible notes 0 31,562
Current portion of lines of credit and notes payable 112,316 5,851
Total current liabilities 396,058 288,321
Operating lease liabilities 18,621  
Convertible notes 203,711 57,299
Deferred tax liabilities, net 116,009 115,193
Other long-term liabilities, principally contract liabilities, contingent consideration and line of credit 78,165 198,968
Total long-term liabilities 416,506 371,460
Total liabilities 812,564 659,781
Equity:    
Common Stock - $0.01 par value, 750,000,000 shares authorized; 616,150,952 and 586,881,720 shares issued at March 31, 2019 and December 31, 2018, respectively 6,162 5,869
Treasury Stock - 549,907 and 549,907 shares at March 31, 2019 and December 31, 2018, respectively (1,791) (1,791)
Additional paid-in capital 3,058,509 3,004,422
Accumulated other comprehensive loss (23,229) (20,131)
Accumulated deficit (1,276,914) (1,197,078)
Total shareholders’ equity 1,762,737 1,791,291
Total liabilities and equity $ 2,575,301 $ 2,451,072